1Division of Nephrology and
4Department of Clinical Biochemistry, Cliniques Universitaires Saint-Luc, Brussels, Belgium;
2Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium;
3Bio and Soft Matter Division (BSMA), Institute of Condensed Mater and Nanosciences, Université Catholique de Louvain, Louvain-la-Neuve, Belgium;
5Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden;
6Baxter Healthcare, Braine-l’Alleud, Belgium;
7Department of Nephrology, Lund University, Skane University Hospital, Lund, Sweden; and
8Institute of Physiology, University of Zurich, Zurich, Switzerland
C.M.O. and O.D. are cosenior authors.
aDeceased.
Published online ahead of print. Publication date available at www.jasn.org.
Correspondence: Prof. Johann Morelle, Division of Nephrology, Cliniques universitaires Saint-Luc, Avenue Hippocrate 10, B-1200 Brussels, Belgium, or Prof. Olivier Devuyst, Institute of Physiology, University of Zurich, Zurich, Switzerland. E-mail: [email protected] or [email protected]